Company: LNAI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001731122-25-001378
Chunk: 67

Company: Lunai Bioworks Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 67
---
 that the Board may amend the Plan at any time, subject to stockholder approval. |

| E. | Pursuant to the authority contained in Section 5.2 of the Plan, the Company now desires to amend the Plan as set forth herein. |

<div align='center'>Amendment</div>

| 1. | The following definitions are added to Section 2: |

“Aggregate Reserve” means the total number of Shares
authorized for issuance pursuant to Awards under Section 4.1 of the Plan, as such number may be adjusted pursuant to Section 15 of the
Plan.

“ISO Pool” means the maximum number of Shares that may
be issued pursuant to Incentive Stock Options under the Plan as set forth in Section 4.1, as such number may be adjusted pursuant to Section
15 of the Plan.

“Evergreen Date” means each July 1 during the period
beginning July 1, 2026 and ending July 1, 2033 on which the Aggregate Reserve may automatically increase pursuant to the Evergreen Increase.

“Evergreen Increase” means the automatic increase in
the number of Shares available for issuance under the Plan on each Evergreen Date as described in Section 4.1.

| 2. | Sub-section (ii) of the definition of “Change in Control” is amended and restated to read: |

(ii) Consummation
of any definitive agreement, which shall not be deemed to occur until the actual consummation of the transaction (and not merely stockholder
approval thereof), the consummation of which would cause to occur:

| 3. | Section 3.3(x) is amended and restated to read: |

(x) to modify the Option Price or SAR Exercise Price
of any outstanding Option or SAR; provided, however, that if any such modification constitutes a repricing, stockholder approval shall
be required before the repricing is effective; and further provided that, notwithstanding anything to the contrary in the Plan: (A) the
Board shall not cancel or exchange any outstanding Option or SAR for a new Option, SAR or other Award with a lower exercise price without
prior stockholder approval and (B) the Board shall not cancel or exchange any outstanding Option or SAR for cash or other property at
a time when the Option Price or SAR Exercise Price exceeds the then-current Fair Market Value of a Share without prior stockholder approval.

<div align='center'>A-2</div>

| 4. |